Dextrose Monohydrate 10% Injection Shortage: Latest Availability and Manufacturer Updates
Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Dextrose Monohydrate 10% Injection remains on the FDA shortage list, though multiple manufacturers currently report that supplies are available.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "low" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, Dextrose-Monohydrate.
Dextrose Monohydrate 10% Injection Shortage Update
What's in Shortage
Dextrose Monohydrate 10% Injection (Brand Name: DEXTROSE) is currently listed on the FDA drug shortage database. This medication is an injection used across several therapeutic categories, including Endocrinology/Metabolism, Gastroenterology, and Pediatrics. The shortage was first posted on March 1, 2022, and the status was last updated on February 2, 2026.
Which Manufacturers Are Affected
While the drug remains on the shortage list, several manufacturers currently report that the product is available.
- Baxter Healthcare: Product is available. (Contact: 888-229-0001)
- Fresenius Kabi USA, LLC: Product is available; however, the manufacturer advises checking with wholesalers for current inventory. (Contact: 888-386-1300)
- B. Braun Medical Inc.: Product is available. (Contact: 800-227-2862)
- Otsuka ICU Medical LLC: Product is available. Note that this product is distributed by ICU Medical. (Contact: 1-866-829-9025 or ProductAvailability@icumed.com)
Why There's a Shortage
The FDA source data does not provide a specific reason for the ongoing shortage of Dextrose Monohydrate 10% Injection.
What Patients Should Do
If you or a family member rely on Dextrose Monohydrate 10% Injection, please consider the following steps:
- Consult Your Healthcare Provider: Always speak with your doctor or healthcare provider regarding your treatment plan and any concerns about medication availability. Do not make changes to your medical regimen without professional guidance.
- Speak with Your Pharmacist: Pharmacists often have the most up-to-date information on local stock and can check with different wholesalers.
- Contact Manufacturers: If you are having difficulty locating the medication, you may use the contact information provided above to inquire about supply status.
Source
Information provided by the FDA Drug Shortage Database.
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Frequently Asked Questions
Common questions about this FDA drug-shortage notice.